XML 26 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 11 - Plant Consolidations
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Plant Consolidation Disclosure [Text Block]
(
11
)
Plant Consolidations
 
Restructuring Costs
 
On
March 18, 2015,
the Company committed to move forward with a plan to cease operations at its Raritan, New Jersey, plant and consolidate operations into its Newburyport, Massachusetts, facility and other UFP facilities. The Company’s decision was in response to a continued decline in business at the Raritan facility and the Company’s purchase of the
137,000
-square-foot facility in Newburyport. The activities related to this consolidation are complete.
 
The Company also relocated all operations in its Haverhill, Massachusetts, and Byfield, Massachusetts, facilities and relocated certain operations in its Georgetown, Massachusetts, facility to Newburyport. The Haverhill and Byfield relocations were complete at
December 31, 2015,
and the partial Georgetown relocation was complete at
June 30, 2017.
 
The Company incurred approximately
$2.1
million in
one
-time expenses in connection with the Massachusetts consolidations. Included in this amount are approximately
$180,000
relating to employee severance payments and relocation costs, approximately
$1.6
million in moving expenses and expenses associated with vacating the Raritan, Haverhill, and Byfield properties, and approximately
$360,000
in lease termination costs. Total cash charges were approximately
$2.0
million.
 
The Company recorded the following restructuring costs associated with the Massachusetts consolidations for the
three
- and
nine
-month periods ended
September 30, 2017
and
2016
(in thousands):
 
    Three Months Ended   Nine Months Ended
    September 30,   September 30,
Restructuring Costs   2017   2016   2017   2016
Relocation   $
-
    $
25
    $
63
    $
203
 
Total   $
-
    $
25
    $
63
    $
203
 
 
Costs for the
three
- and
nine
- month periods ended
September 30, 2017
and
2016
were reclassified in the Condensed Consolidated Statement of Income as “Restructuring Costs” from Cost of Sales.